Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Puig, Noemi
  • Flores-Montero, Juan
  • Burgos, Leire
  • Cedena, Maria-Teresa
  • Perez, Jose-Juan
  • Sanoja-Flores, Luzalba
  • Manrique, Irene
  • Rodriguez-Otero, Paula
  • Rosinol, Laura
  • Martinez-Lopez, Joaquin
  • Mateos, Maria-Victoria
  • Lahuerta, Juan-Jose
  • Blade, Joan
  • San Miguel, Jesus F
  • Orfao, Alberto
  • Paiva, Bruno

Grupos

Abstract

Whereas, in most patients with multiple myeloma (MM), achieving undetectable MRD anticipates a favorable outcome, some others relapse shortly afterwards. Although one obvious explanation for this inconsistency is the use of nonrepresentative marrow samples due to hemodilution, there is no guidance on how to evaluate this issue.

Datos de la publicación

ISSN/ISSNe:
2072-6694, 2072-6694

Cancers  MDPI

Tipo:
Article
Páginas:
-
PubMed:
34638406
Factor de Impacto:
1,349 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 20

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • hemodilution, minimal residual disease, multiple myeloma

Campos de Estudio

Compartir